Robust prospective RCT data on the development of clinical atrial fibrillation (AF) are sparse. We studied the incidence, prevalence and risk factors (RF) for AF in patients enrolled in the… Click to show full abstract
Robust prospective RCT data on the development of clinical atrial fibrillation (AF) are sparse. We studied the incidence, prevalence and risk factors (RF) for AF in patients enrolled in the PRECISION trial. The PRECISION trial investigated the cardiovascular safety of celecoxib compared to
               
Click one of the above tabs to view related content.